Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Regulatory approvals received for new study of Vacc-4x

Dec. 7, 2012

Japan Tobacco applies for approval of single-tablet anti-HIV regimen in Japan

Dec. 7, 2012

Phase I study confirms safety and immunogenicity of HIV vaccine

Dec. 5, 2012

Altravax receives grant from NIH to develop vaccines for HIV/AIDS

Dec. 4, 2012

Theravectys receives clearance for first human trial of anti-HIV vaccine

Dec. 4, 2012

European Commission approves Viread for two new indications

Nov. 28, 2012

Gilead Sciences discloses novel agents for AIDS

Nov. 23, 2012

Chinese researchers present new agents for HIV

Nov. 16, 2012

Novel agents for HIV infection synthesized by Bristol-Myers Squibb

Nov. 15, 2012

FDA approves Prezista 800-mg tablets for the treatment of HIV

Nov. 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....